5-((3-(4-Isobutoxy-3-methylphenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-3-propyl-2-thioxothiazolidin-4-one

Catalog No. :
ACSLAQ169
CAS No. :
623934-84-9
Molecular Formula :
C27H29N3O2S2
Molecular Weight :
491.68

IUPAC Name:(Z)-5-((3-(4-isobutoxy-3-methylphenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-3-propyl-2-thioxothiazolidin-4-one

5-((3-(4-Isobutoxy-3-methylphenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-3-propyl-2-thioxothiazolidin-4-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-((3-(4-Isobutoxy-3-methylphenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-3-propyl-2-thioxothiazolidin-4-one
IUPAC Name(Z)-5-((3-(4-isobutoxy-3-methylphenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-3-propyl-2-thioxothiazolidin-4-one
Molecular FormulaC27H29N3O2S2
Molecular Weight491.68
SMILESO=C1N(CCC)C(S/C1=C\C2=CN(C3=CC=CC=C3)N=C2C4=CC=C(OCC(C)C)C(C)=C4)=S
InChI KeyOZYZUYBXZCEWHP-IWIPYMOSSA-N
SynonymSALOR-INT L431176-1EA;(5Z)-5-([3-(4-ISOBUTOXY-3-METHYLPHENYL)-1-PHENYL-1H-PYRAZOL-4-YL]METHYLENE)-3-PROPYL-2-THIOXO-1,3-THIAZOLIDIN-4-ONE;4-Thiazolidinone, 5-[[3-[3-methyl-4-(2-methylpropoxy)phenyl]-1-phenyl-1H-pyrazol-4-yl]methylene]-3-propyl-2-thioxo-
CAS No.623934-84-9

Synthetic Route by SureRoute

1. ACSLAQ169 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSLAQ169 route product structure diagram
    ACSLAQ169623934-84-9
Inquiry

2. ACSLAQ169 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSLAQ169 route product structure diagram
    ACSLAQ169623934-84-9
Inquiry

Comments (0)